Skip to main content
. 2021 Jun 11;7(6):e07279. doi: 10.1016/j.heliyon.2021.e07279

Table 2.

Rates of treatment completion and comparison of treatment completion patterns for each level of exposure of interest.

Exposure variable Number (%) of Treatment Completers Person-time (100 person-months) Rate of treatment completion (per 100 person-months) (95% CI) p-value of logrank test
Hospital <0.01
 A 155 (65.1) 27.37 5.66 (4.84–6.63)
 B 53 (53.5) 16.21 3.27 (2.50–4.28)
 C 382 (54.8) 79.29 4.82 (4.36–5.33)
Age Group 0.85
 15–29 187 (52.2) 40.62 4.60 (3.99–5.31)
 30–44 232 (60.1) 47.55 4.88 (4.29–5.55)
 45+ 171 (59.0) 34.69 4.93 (4.24–5.73)
Sex of patient <0.01
 Male 428 (55.7) 92.44 4.63 (4.21–5.09)
 Female 162 (61.1) 30.42 5.33 (4.57–6.21)
Place of residence 0.31
 Within Metro Manila 372 (58.8) 75.55 4.92 (4.45–5.45)
 Outside Metro Manila 218 (54.4) 47.29 4.61 (4.04–5.26)
Initial Bacteria Index Value <0.01
 0 96 (69.1) 15.94 6.02 (4.93–7.35)
 1–3 241 (60.9) 43.47 5.54 (4.89–6.29)
 4-6+ 205 (52.4) 50.24 4.08 (3.56–4.68)
 Missing 48 (44.4) 13.22 3.63 (2.74–4.82)
Treatment Extension <0.01
 No treatment extension 457 (53.3) 80.93 5.65 (5.15–6.19)
 Yes, treatment extended 133 (75.1) 41.93 3.17 (2.68–3.76)